Lila Feisee

Array ( [id] => 3554281 [patent_doc_number] => 05543320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Antibodies to interleuken-7 receptors' [patent_app_type] => 1 [patent_app_number] => 8/083243 [patent_app_country] => US [patent_app_date] => 1993-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10832 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543320.pdf [firstpage_image] =>[orig_patent_app_number] => 083243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3451080 [patent_doc_number] => 05385915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-31 [patent_title] => 'Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation' [patent_app_type] => 1 [patent_app_number] => 8/073112 [patent_app_country] => US [patent_app_date] => 1993-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 28 [patent_no_of_words] => 13413 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/385/05385915.pdf [firstpage_image] =>[orig_patent_app_number] => 073112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3960422 [patent_doc_number] => 05885573 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/070116 [patent_app_country] => US [patent_app_date] => 1993-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 16519 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885573.pdf [firstpage_image] =>[orig_patent_app_number] => 070116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657091 [patent_doc_number] => 05591604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Recombinant antibodies at the surface of E. coli' [patent_app_type] => 1 [patent_app_number] => 7/982744 [patent_app_country] => US [patent_app_date] => 1993-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2889 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591604.pdf [firstpage_image] =>[orig_patent_app_number] => 982744 [rel_patent_id] =>[rel_patent_doc_number] =>)